John Wang serves as Executive at Jiangbo Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, John Wang has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 21, 2010 involved receiving (via award) 1,143 shares valued at $0.
John Wang currently holds 2,393 shares of Jiangbo Pharmaceuticals, Inc. (JGBO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Wang has been a net neutral trader of JGBO stock. They have purchased $0 and sold $0 worth of shares.
John Wang's most recent insider trade was on Apr 21, 2010, when they sold 1,143 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |